Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication indicated for attention deficit hyperactivity disorder in youngsters and grown-ups . In Canada, its distribution is overseen by Health https://vyvanseincanada389348.gamesbloggo.com/61709151/lisdexamfetamine-in-canada-a-detailed-guide